Fig. 1From: Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemiaPatient flow diagram. * This patient had an objective response in achieving MRD-negative in BM and CSF and reduction in extramedullary disease. SCT—stem cell transplantation; CR—complete remission; CCR—continuous complete remission; NR—no response; PR—partial remission; DLT—dose limited toxicity; mos—monthsBack to article page